This variation in treatment effect is suspected to be due to differences in medications, differences in methodology for lean mass assessment, and different lifestyle interventions prescribed in combination with pharmacological therapies [71]
They will determine your eligibility for various programs
Thus, TZT, through activation of both GIP and GLP-1, may reduce obesity-mediated inflammation
Many patients who experience nausea, constipation, or other GI side effects on one medication tolerate the other well, making a switch a clinically sound option worth discussing with your PlexusDx provider
But this type of testing requires specialized equipment, trained personnel, and deliberate intent to screen for GLP-1 agonists
"It's a completely different model of metabolic flexibility." These natural examples of metabolic control have caught the attention of major pharmaceutical companies